Results 281 to 290 of about 769,984 (331)
Some of the next articles are maybe not open access.
Progressive Systemic Sclerosis
Clinics in Rheumatic Diseases, 1983To date, largely because of convenience, therapeutic trials in progressive systemic sclerosis have been few and largely short-term retrospective single institution studies. For the future, there is a pressing need to expand efforts in this area to include: controlled, prospective studies with adequate numbers of patients employing, if necessary, a ...
openaire +3 more sources
Progressive Systemic Sclerosis
The Nurse Practitioner, 1982Progressive systemic sclerosis is a disease of uncertain etiology associated with vascular/collagen tissue changes that may affect only the skin (scleroderma) or any and all internal organs (PSS). A disease primarily of Caucasian females, PSS is usually manifested in the fourth to sixth decade of life.
Linda B. Pearson, Linna Walker
openaire +3 more sources
Ketanserin in the Treatment of Progressive Systemic Sclerosis
Angiology, 1988Now progressive systemic sclerosis (PSS) is considered a disease of small vessels with which many immunologic alterations are associated. The presence in the blood of large amounts of serotonin can be considered a very important aggravating factor able to cause the sclerodermic alterations.
G. F. Altomare +2 more
openaire +3 more sources
Epidemiology of Progressive Systemic Sclerosis
Clinics in Rheumatic Diseases, 1979SUMMARY Although PSS may at times be difficult to distinguish from closely related disorders, especially early in its course, a characteristic set of cutaneous and visceral manifestations are helpful in differentiation. The cutaneous sclerosis characteristic of the disease varies in extent from classic diffuse (generalized) scleroderma to the ...
Thomas A. Medsger, Alfonse T. Masi
openaire +2 more sources
Anorectal abnormalities in progressive systemic sclerosis [PDF]
Diseases of the Colon & Rectum, 1989 Seventeen patients with progressive systemic sclerosis (PSS) were evaluated with manometry for anorectal function, and an additional 36 age-matched normal subjects were collected as a control group. The study group had a significant decrement of maximum basal pressure (MBP), 42.6 +/- 27.0 mm Hg, in PSS as compared with the control group, 71.2 +/- 24.9 ...
Jen-Kou Lin +2 more
openaire +2 more sources
Lungs in progressive systemic sclerosis
British Journal of Diseases of the Chest, 1970Summary Impairment of pulmonary function in scleroderma is commoner than would be expected on clinical or radiological grounds alone. There is a poor correlation between the severity of functional derangement and the extent of pulmonary lesion detectable by clinical or radiological means.
J.S. Guleria +3 more
openaire +2 more sources
Penicillamine and Progressive Systemic Sclerosis
Annals of Internal Medicine, 1983Excerpt To the editor: Steen and associates (1) have attempted to draw conclusions about the effect of D-penicillamine on the natural history of progressive systemic sclerosis with diffuse sclerode...
openaire +3 more sources
Some Progress with Systemic Sclerosis
Annals of Internal Medicine, 1979Excerpt The treatment of systemic sclerosis has been ineffectual despite past enthusiasm for some drugs, notably corticosteroids, dimethyl sulfoxide, epsilon aminocaproic acid, potassium para-amino...
openaire +3 more sources
Impotence in Progressive Systemic Sclerosis
Annals of Internal Medicine, 1982Excerpt To the editor: Lally and Jimenez (1) suggest that impotence may be an early presenting symptom in progressive systemic sclerosis. Unfortunately their evidence for this conclusion is weak.
openaire +3 more sources
Progressive Systemic Sclerosis and Impotence
Annals of Internal Medicine, 1981Excerpt To the editor: We were most interested to read the recent article by Lally and Jimenez (1) describing six patients with progressive systemic sclerosis and impotence for whom no cause for th...
Lawrence E. Klein, Marc S. Posner
openaire +2 more sources